Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Prevention of Type 2 Diabetes in Subjects with IGT
NCT01038648Phase 3Withdrawn
- Sponsor
- Dr. A. Ramachandran's Diabetes Hospitals
- Start
- Dec 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Dr. A. Ramachandran's Diabetes Hospitals. Planned start Dec 2011; status: withdrawn.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01038648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038648.